A Pennsylvania woman is one of the first patients in the country to receive a new FDA-approved treatment for early symptomatic Alzheimer’s disease.
Karen Chung, 63, from Chester Springs, has received her first dose of Kisunla, Eli Lilly and Company’s Alzheimer’s treatment for adults, specifically with early symptomatic Alzheimer’s disease.
“I’m so thrilled to be here because we’ve been bitting at the bit to get first of all a diagnosis but then somehow a treatment or something that’s going to help me. I’m thrilled to be here,” said Chung…